PLK1 and survivin in diffuse large B-cell lymphoma

被引：0

作者：

Schmidt, Mathias ^{[1
]}

机构：

[1] Nycomed GmbH, D-78467 Constance, Germany

来源：

LEUKEMIA & LYMPHOMA | 2007年 / 48卷 / 11期

关键词：

D O I：

10.1080/10428190701593669

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2089 / 2090

页数：2

共 6 条

[1]

HARRIS NL, 1994, BLOOD, V84, P1361

[2]

Jaffe E.S., 2001, PATHOLOGY GENETICS T, V3

[3] Expression of PLK1 and survivin in diffuse large B- cell lymphoma [J].

Liu, Lin ;

Zhang, Min ;

Zou, Ping .

LEUKEMIA & LYMPHOMA, 2007, 48 (11) :2179-2183

[4] Mitotic drug targets and the development of novel anti-mitotic anticancer drugs [J].

Schmidt, Mathias ;

Bastians, Holger .

DRUG RESISTANCE UPDATES, 2007, 10 (4-5) :162-181

[5] A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA [J].

SHIPP, MA ;

HARRINGTON, DP ;

ANDERSON, JR ;

ARMITAGE, JO ;

BONADONNA, G ;

BRITTINGER, G ;

CABANILLAS, F ;

CANELLOS, GP ;

COIFFIER, B ;

CONNORS, JM ;

COWAN, RA ;

CROWTHER, D ;

DAHLBERG, S ;

ENGELHARD, M ;

FISHER, RI ;

GISSELBRECHT, C ;

HORNING, SJ ;

LEPAGE, E ;

LISTER, TA ;

MEERWALDT, JH ;

MONTSERRAT, E ;

NISSEN, NI ;

OKEN, MM ;

PETERSON, BA ;

TONDINI, C ;

VELASQUEZ, WA ;

YEAP, BY .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :987-994

[6] Polo-like kinases (Plks) and cancer [J].

Takai, N ;

Hamanaka, R ;

Yoshimatsu, J ;

Miyakawa, I .

ONCOGENE, 2005, 24 (02) :287-291

← 1 →